ArticleACS medicinal chemistry letters2025
Novel Fused Heterocycles as 5‑HT2A Receptor Agonists for Treating Neurological Diseases, Namely, Depression, Anxiety, Substance Abuse, and Headaches.
Ram W SabnisPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.